This initiative aims to produce eco-friendly bio-based molecules from low-cost, eco-friendly sources. Key benefits include:
Cost-parity with conventional methods: Unlike existing bio-based molecules production, this initiative aims to achieve cost-parity with conventional processes by utilising low-cost renewable sources like methanol.
Wide-ranging industry applications: The sustainable bio-based molecules produced can be used for wide-ranging industrial applications in textiles, automotive, personal care, and coatings industries.
Boosting Singapore's green economy: This effort strengthens Singapore's leadership in the global bioeconomy, which can lead to high-value job creation in sustainable biomanufacturing.
SINGAPORE – MojiaBio, a leading innovator in green chemistry and sustainable biomanufacturing, will be developing an SGD 44.8 million state-of-the-art Sustainable Biomanufacturing Technology Platform (SBTP) with the Agency for Science, Technology and Research (A*STAR). By integrating advanced synthetic biology and bioprocessing innovations, the SBTP aims to position Singapore as a global leader in sustainable biomanufacturing, accelerating the transition to a circular bioeconomy and net-zero future.
Unlike other existing bio-based molecules in the market, the SBTP aims to pioneer the production of a range of high-value bio-based molecules that are cost-competitive and serve the needs of various industries. This is made possible due to the innovative use of cost-effective sources like methanol and ethylene glycol, which enables the platform to produce scalable, sustainable alternatives to conventional chemical processes. This includes the production of 1,3-propanediol (PDO), a key ingredient for a broad array of industries such as skincare products, coatings and biodegradable plastics.
Building Singapore's Capabilities in Green Biomanufacturing
Comments powered by CComment